BioSpace News Archive

Lantheus Holdings, Inc. reported financial results for its fourth quarter and full year ended December 31, 2018.

Castlight Health, Inc. will release its fourth quarter and fiscal year 2018 financial results on Thursday, February 28, 2019, after the market close.

Eagle Pharmaceuticals, Inc. announced that the Company will release its 2018 fourth quarter and full year financial results on Thursday, February 28, 2019, before the market opens.

Fengate Asset Management is pleased to announce two recent United States public-private partnership industry awards recognizing, respectively, Mac Bell, Director and Head of P3 Investments, and a P3 project that Fengate is proud to be a part of.

The Society for Research on Nicotine and Tobacco (SRNT) conference along with the American Academy of Allergy, Asthma and Immunology (AAAAI) conference are happening this weekend in San Francisco. UNC School of Medicine (SOM) experts will be available for comment on newly released research and trending topics.

Kibow Biotech is proud to announce its 22nd year of operations and that it is the pioneer with the use of Pro/Prebiotics in people with failing kidneys.

Teva Pharmaceutical Industries Ltd. announced a settlement with the Federal Trade Commission that will resolve all outstanding litigation between the parties.

Aquestive Therapeutics, Inc. announced that it will report results for the fourth quarter and full year ended December 31, 2018 and provide a business update on Thursday, March 14, 2019 before the market open.

Healthcare Finance unit served as joint lead arranger and administrative agent on the first-lien credit facility for the acquisition of KabaFusion, a leading provider of acute and specialty home infusion services, by Pritzker Private Capital.

Survey of more than 2,000 beneficiaries also found that most are happy with their Medicare benefits and believe all Americans should have Medicare-like coverage